- Inhibition of the breast cancer by PPARγ agonist pioglitazone through…
Number of the records: 1  

Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway

  1. Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway / X. X. Jiao ... [et al.]. -- ilustr., aj fareb., grafy, obr. -- Bibliogr. odkazy. -- Res. angl.
    In: Neoplasma. -- ISSN 0028-2685. -- Vol. 67, no. 4 (2020), s. 834-842.
    nádory prsníka * PPAR gama - agonisty * pioglitazón * línia bunková nádorová * myši inbredné BALB C * štúdia experimentálna
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.